Mathieu Bigois
Finanzdirektor/CFO bei DrugAbuse Pharmaceutical, Inc.
Profil
Mathieu Bigois has been Vice President of Finance and Business Development for DrugAbuse Pharmaceutical, Inc. since September, 2003.
Prior to joining DrugAbuse Pharmaceutical, he was Director of Finance for DrugAbuse Sciences SAS.
Previously, Mr. Bigois worked at Wasserstein Perella & Co. and Credit Suisse First Boston.
He received an undergraduate degree from Ecole Centrale Paris and an MS degree in Finance and Economics from the University of London.
Aktive Positionen von Mathieu Bigois
Unternehmen | Position | Beginn |
---|---|---|
DrugAbuse Pharmaceutical, Inc.
DrugAbuse Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology DrugAbuse Pharmaceuticals, Inc. develops medications for the treatment of alcohol and other drug addictions. The company is headquartered in Lexington, MA. | Finanzdirektor/CFO | - |
Bounty Brands Holdings Ltd.
Bounty Brands Holdings Ltd. Food DistributorsDistribution Services Bounty Brands Holdings Ltd. offers comprehensive solutions to local and international consumer brands. The private company is based in London, UK, and has subsidiaries in South Africa. The British company's services include design and brand management, manufacturing, distribution, scalable platforms, route-to-market partnerships, omnichannel capabilities, and regional relevance. Bounty Brands Holdings was founded in 2016, and the CEO is Stefan Rabe. | Direktor/Vorstandsmitglied | 01.05.2019 |
Ehemalige bekannte Positionen von Mathieu Bigois
Unternehmen | Position | Ende |
---|---|---|
DrugAbuse Sciences SAS
DrugAbuse Sciences SAS Pharmaceuticals: MajorHealth Technology DrugAbuse Sciences SAS develops therapies for treatment of alcohol abuse and opiate addiction. It also operates an educational website which is designed to provide clinicians, patients access to information and services related to alcohol abuse treatment and care. The company is headquartered in Lyon, France | Finanzdirektor/CFO | 23.09.2008 |
Ausbildung von Mathieu Bigois
University of London | Graduate Degree |
École Centrale Paris | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
DrugAbuse Pharmaceutical, Inc.
DrugAbuse Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology DrugAbuse Pharmaceuticals, Inc. develops medications for the treatment of alcohol and other drug addictions. The company is headquartered in Lexington, MA. | Health Technology |
DrugAbuse Sciences SAS
DrugAbuse Sciences SAS Pharmaceuticals: MajorHealth Technology DrugAbuse Sciences SAS develops therapies for treatment of alcohol abuse and opiate addiction. It also operates an educational website which is designed to provide clinicians, patients access to information and services related to alcohol abuse treatment and care. The company is headquartered in Lyon, France | Health Technology |
Bounty Brands Holdings Ltd.
Bounty Brands Holdings Ltd. Food DistributorsDistribution Services Bounty Brands Holdings Ltd. offers comprehensive solutions to local and international consumer brands. The private company is based in London, UK, and has subsidiaries in South Africa. The British company's services include design and brand management, manufacturing, distribution, scalable platforms, route-to-market partnerships, omnichannel capabilities, and regional relevance. Bounty Brands Holdings was founded in 2016, and the CEO is Stefan Rabe. | Distribution Services |